Repaglinide

Prandin

Pictures

27R045 jpg

27R045 Repaglinide 1mg Tab 現行藥物外觀 中文名 諾和隆錠

---

27R045 jpg

27R045 Repaglinide 1mg Tab 現行藥物外觀 中文名 諾和隆錠

---

paradin jpg

Repaglinide is marketed in the US under the trade mark Prandin� while in the rest of the world it will be known as NovoNorm® Promising launch

---

rtarescrepaglinideoraltablet jpg

REPAGLINIDE Oral Tablet

---

clip image007 png

Fig 1 Permeation of Repaglinide across cadaver human skin Fig 2 Plots of cumulative percent drug permeated versus square root of time

---

clip image004 png

Enhancement Factor 1 18 1 27 1 45 1 64 1 32 Fig 1 Permeation of Repaglinide across cadaver human skin

---

nomopil jpg

Nomopil

---

focus jpg

---

main jpg

---

idm12005table11 gif

Table I Parameters of cardiovascular risk before and after 12 months treatment with repaglinide or metformin

---

faq jpg

---

main 01 jpg

---

185 195 innolet jpg

---

blood jpg

---

diet jpg

---

main jpg

---

1452002CRfig3 gif

that the use of repaglinide is safe in patients with mild to moderate renal impairment dose adjustments are necessary only when there is severe renal impairment Fig 1 Area under the curve AUC and half life t1 2 of repaglinide are unaffected by renal function in patients with mild to moderate or no renal impairment Data

---

links jpg

---

art tu03 fig06 gif

nateglinide and insulin address the decline in insulin secretion AGIs reduce glucose influx metformin and insulin blunt hepatic glucose output and TZDs enhance peripheral glucose uptake Figure 6 Matching pharmacology to pathophysiologic mechanisms underlying hyperglycemia Insulin and insulin analogues repaglinide nateglinide and AGIs largely target PPG Bedtime

---

drug33 jpg

---